Home ›
NPI 1730570466
NPI deactivated
1730570466
1730570466 was paid $123.46 by Medicaid between Jun 2020 and Jan 2021, across 29 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 81% of everything it billed.
33Billing provider info1730570466
33aNPI1730570466
33bProvider type—
28Total paid$123.46
24GClaims4,469
24DCodes billed29
24AFirst – last monthJun 2020 – Jan 2021
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 4,160 | $123.46 | |
| 2021 | 309 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 81% | 577 | 474 | $100.00 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 19% | 744 | 577 | $23.46 |
| 81404 | 0% | 59 | 59 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 274 | 181 | $0.00 |
| 81439 | 0% | 59 | 59 | $0.00 | |
| 81405 | 0% | 59 | 59 | $0.00 | |
| 81408 | 0% | 59 | 59 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 165 | 130 | $0.00 |
| 87150 | 0% | 167 | 132 | $0.00 | |
| 87481 | 0% | 25 | 24 | $0.00 | |
| 87631 | 0% | 139 | 105 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 139 | 105 | $0.00 |
17 more codes
| 87265 | 0% | 139 | $0.00 | |
| 81403 | 0% | 59 | $0.00 | |
| 81406 | 0% | 59 | $0.00 | |
| 87653 | 0% | 96 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 88 | $0.00 |
| 87541 | 0% | 139 | $0.00 | |
| 87640 | 0% | 272 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 176 | $0.00 |
| 87485 | 0% | 139 | $0.00 | |
| 87483 | 0% | 139 | $0.00 | |
| 87581 | 0% | 227 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 0% | 25 | $0.00 |
| 87181 | 0% | 165 | $0.00 | |
| 87486 | 0% | 88 | $0.00 | |
| 81407 | 0% | 59 | $0.00 | |
| 87498 | 0% | 88 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.